Chandigarh, 5th February 2025: Tata Chemicals Limited today declared its financial results for the quarter and nine months ended December 31, 2024.

On a consolidated basis, for the current quarter (‘Q3FY25’), the income from operations stood at ₹ 3,590 Cr as compared to ₹ 3,730 Cr in Q3FY24. EBITDA stood at ₹ 434 Cr as compared to ₹ 542 Cr in Q3FY24. PAT (before exceptional items and non-controlling Interest (‘NCI’)) from continuing operations stood at ₹ 49 Cr as compared to ₹ 194 Cr in Q3FY24.

On a standalone basis, for Q3FY25, the income from operations at ₹ 1,166 Cr as compared to ₹ 1,093 Cr in Q3FY24. EBITDA at ₹ 209 Cr as compared to ₹ 206 Cr in Q3FY24. PAT at ₹ 72 Cr as compared to ₹ 115 Cr in Q3FY24.

Commenting on the results, R. Mukundan, Managing Director & CEO, Tata Chemicals Limited, said, “Overall Asia including India continue to experience growth, while other markets including US and Western Europe are witnessing slight decline due to reduced demand for flat and container glass. Company’s overall performance was down as compared to the same quarter of previous year, mainly due to lower Soda Ash pricing across geographies and higher fixed cost in US due to plant production outage during the quarter.

Our endeavour is to maximize sales through customer engagement, while ensuring steady contribution margins with a focus on cost optimization. In the short term, current demand – supply adverse situation is likely to persist but should improve and stabilise over the long term driven by growth sectors based on sustainability trends.”

Consolidated Highlights Q3FY25

•  Revenue from operations stood at ₹ 3,590 Cr, down by 4% compared to Q3FY24, mainly on account of adverse price movement of Soda Ash
•  EBITDA for the quarter stood at ₹ 434 Cr, down by 20% compared to Q3FY24.
•  Profit After Tax (before exceptional items and NCI) from continuing operations was ₹ 49 Cr compared to ₹ 194 Cr for Q3FY24.
•  An exceptional charge of ₹ 70 Cr consisting of estimated expenses related to employee termination benefits, decommissioning of plant and machinery, and other closure-related incidental expenses was taken in Q3FY25, in relation to cessation of Soda ash production at the Lostock plant in Northwich, UK.
•  Gross debt as on December 31, 2024, stood at ₹ 6,722 Cr up by ₹ 810 Cr and net debt at ₹ 5,329 Cr up by ₹ 952 Cr, compared to December 31, 2023, on account of lower EBITDA and higher working capital (US, Kenya & India).
•  70 KTPA Pharma Salt plant commissioned in UK.
•  Sales and Production volumes of Soda Ash, Bicarb and Salt were higher than Q3FY24.

Standalone Highlights Q3FY25

•  Revenue from operations stood at ₹ 1,166 Cr, up by 7% compared to Q3FY24.
•  EBITDA at ₹ 209 Cr, up by 1% compared to Q3FY24.
•  Profit After Tax from continuing operations was ₹ 72 Cr, down by 37% compared to Q3FY24.
•  FOS sales on track leading to full utilization of capacity.